AzTrials
AzTrials

Radiculopathy LumbarOPTI-DTINCT04224077

Diffusion Tensor Sequences (DTI) for Study of Lumbar Roots by Magnetic Resonance Imaging (MRI)

A study testing Optimisation of DTI sequences in people with Radiculopathy Lumbar and MRI, run by Lille Catholic University at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Diffusion tensor imaging (DTI) is a non-invasive MRI technique offering a functional approach that provides morphological information about the microstructures of the nerve roots. DTI is a widely used neuroimaging technique and is a current topic of research in the field of peripheral nerve imaging. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
What is being tested?
Optimisation of DTI sequences
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteFrance
Study dates
10 Feb 2020to 31 Aug 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Person without history of lumbar surgery
  • Person who has previously consented

Who cannot join

  • MRI contraindications (pace maker, cardiac defibrillator,...)
  • Claustrophobia
  • Pregnant woman
  • Person without social security
  • Person with a guardianship
  • Person carrying metallic surgical material (spine, pelvis, abdomen)

Trial locations and contacts

1 site in 1 country.

France1 site
  • Lille Catholic Hospitals

    Lomme, 59462

Other trials in France

About this study

Official title: Optimisation of Diffusion Tensor Sequences (DTI) for Study of Lumbar Roots by Magnetic Resonance Imaging (MRI) : a Feasibility Study

Diffusion tensor imaging (DTI) is a non-invasive MRI technique offering a functional approach that provides morphological information about the microstructures of the nerve roots. DTI is a widely used neuroimaging technique and is a current topic of research in the field of peripheral nerve imaging. The aim of this work is therefore to improve DTI sequences by specifically evaluating the contribution of the multiband technique in healthy volunteers.

Read the detailed description

For every healthy volunteer will be acquired:

  • a morphological sequence
  • a reference diffusion tensor sequence covering three lumbar stages (reference DTI),
  • a diffusion tensor sequence acquired in multiband technique, covering three lumbar stages (optimized DTI),
  • a diffusion tensor sequence acquired in a multiband technique, covering a lumbar stage, of higher spatial resolution (centred DTI)
Being tested
Optimisation of DTI sequences
Keywords
Radiculopathy Lumbar, MRI, Diffusion tensor imaging, Multiband technique

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Optimisation of DTI sequencesDiagnostic test

    Optimisation of DTI sequences in the study of lumbar roots by MRI

Study groups in NCT04224077
Study groupRoleWhat they receive
InterventionExperimentalHealthy volunteers
Receives: Diagnostic Test: Optimisation of DTI sequences

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Image quality measured as signal-to-noise ratio and contrast-to-noise ratio

    Comparison of the image quality between DTI optimized and DTI of reference. The signal-to-noise ratio is a measure that compares the level of a desired signal to the level of background noise. Mathematically, the signal-to-noise ratio is the quotient of the (mean) signal intensity measured in a region of interest and the standard deviation of the signal intensity in a region outside the anatomy of the object being imaged.

    The contrast-to-noise ratio is a measure of image quality based on a contrast rather than the raw signal.

    Measured: Day 0

Secondary outcomes (3)
  1. Fraction of anisotropy and apparent diffusion coefficient

    Comparison of fraction of anisotropy, and apparent diffusion coefficient between DTI optimized and DTI of reference.

    The measurement of fraction of anisotropy, and apparent diffusion coefficient provides robust values for quantifying the degree of microstructural abnormalities of nerves.

    Measured: Day 0

  2. Concordance of observed agreement measured by Cohen's kappa coefficient

    Evaluation of interobserver accordance for multiband acquisitions (optimized DTI)

    Measured: Day 0

  3. Concordance of observed agreement measured by Intra-class correlation coefficient

    Evaluation of interobserver accordance for multiband acquisitions (optimized DTI)

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2020
  2. Study start10 Feb 2020
  3. Primary completion10 Feb 2020
  4. Study completion31 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04224077
Sponsor's protocol ID
RC-P0060
Acronym
OPTI-DTI
Status last verified
Feb 2021
First submitted
8 Jan 2020
Last updated
3 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Optimisation of DTI sequences in people with Radiculopathy Lumbar and MRI, run by Lille Catholic University at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Image quality measured as signal-to-noise ratio and contrast-to-noise ratio (time frame: Day 0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in